Inpixon Toekomstige groei

Future criteriumcontroles 0/6

Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Inpixon te voorspellen.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

IT winstgroei	15.2%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Geen updates

Recent updates

Even With A 179% Surge, Cautious Investors Are Not Rewarding Inpixon's (NASDAQ:INPX) Performance Completely

Apr 17

Examining The Sysorex, Inpixon, And TTM Digital Assets Reverse Triangular Merger For Opportunities

Jun 01

Inpixon buys SaaS app platform

May 03

Inpixon acquires AR, computer vision and 3D reconstruction technologies from Visualix

Apr 26

Inpixon prices $10M registered direct offering

Nov 27

Inpixon's mapping platform chosen by pharmaceutical company to facilitate tracking of COVID-19 vaccine-related assets, shares up 7%

Nov 18

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Inpixon onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

NasdaqCM:INPX - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
9/30/2023	10	-39	-33	-32	N/A
6/30/2023	19	-68	-31	-30	N/A
3/31/2023	20	-75	-29	-28	N/A
12/31/2022	11	-51	-35	-34	N/A
9/30/2022	6	-47	-41	-40	N/A
6/30/2022	15	-110	-44	-43	N/A
3/31/2022	16	-81	-49	-47	N/A
12/31/2021	10	-40	-39	-37	N/A
9/30/2021	15	-43	-34	-29	N/A
6/30/2021	13	-14	-29	-24	N/A
3/31/2021	10	-36	-26	-22	N/A
12/31/2020	9	-29	-25	-21	N/A
9/30/2020	7	-38	-19	-17	N/A
6/30/2020	6	-37	-15	-14	N/A
3/31/2020	7	-35	-13	-12	N/A
12/31/2019	6	-35	-12	-11	N/A
9/30/2019	6	-34	-14	-12	N/A
6/30/2019	5	-31	-17	-15	N/A
3/31/2019	4	-40	-20	-19	N/A
12/31/2018	4	-40	-28	-27	N/A
9/30/2018	4	-29	-22	-21	N/A
6/30/2018	3	-31	-18	-17	N/A
3/31/2018	-9	-19	-11	-10	N/A
12/31/2017	4	-19	1	2	N/A
9/30/2017	18	-26	-3	-1	N/A
6/30/2017	28	-26	N/A	-1	N/A
3/31/2017	53	-28	N/A	-1	N/A
12/31/2016	53	-26	N/A	-3	N/A
9/30/2016	59	-17	N/A	-5	N/A
6/30/2016	63	-16	N/A	-4	N/A
3/31/2016	67	-13	N/A	-6	N/A
12/31/2015	67	-12	N/A	-8	N/A
9/30/2015	62	-10	N/A	-2	N/A
6/30/2015	61	-9	N/A	-3	N/A
3/31/2015	61	-10	N/A	-6	N/A
12/31/2014	63	-8	N/A	-5	N/A
9/30/2014	64	-7	N/A	-7	N/A
6/30/2014	64	-6	N/A	-6	N/A
3/31/2014	62	-4	N/A	-2	N/A
12/31/2013	51	-4	N/A	-3	N/A
9/30/2013	35	-3	N/A	-3	N/A
6/30/2013	22	-3	N/A	-3	N/A
3/31/2013	8	-2	N/A	-1	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van INPX boven de spaarquote ( 2.3% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van INPX naar verwachting sneller zal groeien dan de markt US

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van INPX naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van INPX naar verwachting sneller zal groeien dan de markt US.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van INPX naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van INPX naar verwachting over 3 jaar hoog zal zijn

Inpixon Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Inpixon has withdrawn its Follow-on Equity Offering in the amount of $10 million.

Inpixon has withdrawn its Follow-on Equity Offering in the amount of $10 million.

Inpixon(NasdaqCM:INPX) dropped from NASDAQ Composite Index

Inpixon has filed a Follow-on Equity Offering in the amount of $10 million.

Inpixon announced delayed 10-Q filing

Insufficient new directors

Inpixon to Report Q3, 2023 Results on Nov 14, 2023

Inpixon announced delayed 10-Q filing

Insufficient new directors

Inpixon to Report Q2, 2023 Results on Aug 14, 2023

XTI Aircraft Company entered into a definitive merger agreement to acquire Inpixon (NasdaqCM:INPX) in a reverse merger transaction.

XTI Aircraft Company entered into a definitive merger agreement to acquire Inpixon (NasdaqCM:INPX) in a reverse merger transaction.

Inpixon announced delayed 10-Q filing

First quarter 2023 earnings released: US$0.98 loss per share (vs US$9.40 loss in 1Q 2022)

Inpixon to Report Q1, 2023 Results on May 15, 2023

Even With A 179% Surge, Cautious Investors Are Not Rewarding Inpixon's (NASDAQ:INPX) Performance Completely

Full year 2022 earnings released: US$27.18 loss per share (vs US$53.70 loss in FY 2021)

Third quarter 2022 earnings released: US$11.35 loss per share (vs US$21.43 loss in 3Q 2021)

Insufficient new directors

Inpixon to Report Q3, 2022 Results on Nov 14, 2022

Inpixon Reports Compliance with Nasdaq's Listing Requirement

Inpixon, Annual General Meeting, Nov 28, 2022

Inpixon stock slides after pricing $15M securities offering

Is Inpixon (NASDAQ:INPX) Using Debt In A Risky Way?

Inpixon Achieves FCC, ISED Certifications and Establishes CE Status for Inpixon Swarm Chirp V3

Second quarter 2022 earnings released: US$0.097 loss per share (vs US$0.13 profit in 2Q 2021)

Inpixon Non-GAAP EPS of -$0.07, revenue of $4.73M

Inpixon to Report Q2, 2022 Results on Aug 15, 2022

Insufficient new directors

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Inpixon to Report Q1, 2022 Results on May 16, 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Inpixon Brings UWB and Chirp RTLS to Award-Winning Inpixon Aware

Inpixon Secures Broad Patent Protection for Use of Sensor Fusion to Determine Location

Inpixon Launches Active Tag for Long-Range, Real-Time Location System (RTLS) Asset Tracking

Inpixon wins multi-year contract for smart office app

Examining The Sysorex, Inpixon, And TTM Digital Assets Reverse Triangular Merger For Opportunities

Inpixon (NasdaqCM:INPX) acquired Design Reactor, Inc. from Leon Papkoff.

Inpixon buys SaaS app platform

Inpixon acquires AR, computer vision and 3D reconstruction technologies from Visualix

Inpixon to Report Fiscal Year 2020 Results on Mar 25, 2021

Inpixon to Provide Co2 Sensors to Help Identify COVID-19 Infection Risk

Inpixon Launches Next-Generation RTLS Anchor for Integrators and OEMs

Inpixon Releases Enhanced Inpixon Aware Security Solution

Inpixon Enters Contract for Nearly One Million Square Feet of Mapping

Inpixon Releases High-Performance, Real-Time Location System Server Enhancements

Inpixon Enhances Enterprise-Class and Social Distancing Features with New Inpixon Mapping Release

Inpixon prices $10M registered direct offering

Leading Pharmaceutical Corporation Selects Inpixon Mapping to Facilitate Tracking of COVID-19 Vaccine-Related Assets

Inpixon's mapping platform chosen by pharmaceutical company to facilitate tracking of COVID-19 vaccine-related assets, shares up 7%

Inpixon Announces Availability of Location Intelligence Products Through Global Distributor Digi-Key

Inpixon to Report Q3, 2020 Results on Nov 12, 2020

Inpixon Launches Advanced RTLS Tag Module for Real-Time Positioning

Sysorex Global Holdings Corp. (OTCPK:SYRX) completed the acquisition of AirPatrol Corporation for $29.3 million.

Inpixon to Report Q2, 2020 Results on Aug 13, 2020

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven